Future therapy for inflammatory bowel disease: Should we rethink what we mean by “Top Down”? Michael J. G. Farthing Invited Commentary 03 October 2007 Pages: 355 - 357
Is functional bowel disease really functional? Joseph H. Sellin Clinical Trials Report 03 October 2007 Pages: 363 - 364
Evaluation of small bowel bacterial overgrowth Lawrence R. Schiller OriginalPaper 03 October 2007 Pages: 373 - 377
Post-infectious irritable bowel syndrome Andrew W. DuPont OriginalPaper 03 October 2007 Pages: 378 - 384
Commensal bacteria and epithelial cross talk in the developing intestine Samuli RautavaW. Allan Walker OriginalPaper 03 October 2007 Pages: 385 - 392
The role of probiotics in management of irritable bowel syndrome Anna M. BorowiecRichard N. Fedorak OriginalPaper 03 October 2007 Pages: 393 - 400
Refractory celiac disease Hani AbdallahDaniel LefflerCiarán P. Kelly OriginalPaper 03 October 2007 Pages: 401 - 405
Looking beyond the mucosal surface: Optical coherence tomography in the colon Lawrence R. Schiller Clinical Trials Report 03 October 2007 Pages: 409 - 409
Appropriate use of laxatives in the management of constipation Arnold Wald OriginalPaper 03 October 2007 Pages: 410 - 414
Adjuvant therapy for Colon Cancer Olivia AranhaAl B. Benson OriginalPaper 03 October 2007 Pages: 415 - 421
Isolated colonic ulcers: Diagnosis and management Anil B. Nagar OriginalPaper 03 October 2007 Pages: 422 - 428
Amebic colitis: New insights into pathogenesis and treatment Tracy E. BercuWilliam A. PetriBrian W. Behm OriginalPaper 03 October 2007 Pages: 429 - 433
Probiotics in the management of colonic disorders Eamonn M. M. Quigley OriginalPaper 03 October 2007 Pages: 434 - 440
